These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 374171

  • 1. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M, Kawamori R, Abe H.
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [Abstract] [Full Text] [Related]

  • 2. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R, Shichiri M, Kikuchi M, Yamasaki Y, Abe H.
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [Abstract] [Full Text] [Related]

  • 3. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
    Ross SA, Brown JC, Dupré J.
    Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
    [Abstract] [Full Text] [Related]

  • 4. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
    Hanna AK, Zinman B, Nakhooda AF, Minuk HL, Stokes EF, Albisser AM, Leibel BS, Marliss EB.
    Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
    [Abstract] [Full Text] [Related]

  • 5. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA, Dupre J.
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [Abstract] [Full Text] [Related]

  • 6. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T, Raskin P, Aydin I, Unger R.
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [Abstract] [Full Text] [Related]

  • 7. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A, Schultz M, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979 May; (8):93-6. PubMed ID: 395097
    [Abstract] [Full Text] [Related]

  • 8. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis.
    O'Brien TD, Hayden DW, Johnson KH, Stevens JB.
    Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345
    [Abstract] [Full Text] [Related]

  • 9. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies.
    Tiengo A, Del Prete GF, Nosadini R, Betterle C, Garotti C, Bersani G.
    Diabetologia; 1977 Sep; 13(5):451-8. PubMed ID: 332569
    [Abstract] [Full Text] [Related]

  • 10. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE.
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [Abstract] [Full Text] [Related]

  • 11. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
    Katsura M.
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov 20; 62(11):1276-88. PubMed ID: 3542595
    [Abstract] [Full Text] [Related]

  • 12. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang NS.
    Diabetes; 1977 Jan 20; 26(1):36-45. PubMed ID: 830563
    [Abstract] [Full Text] [Related]

  • 13. An 'artificial beta cell' for control of diabetes mellitus: effect on plasma glucagon levels.
    Horwitz DL, Gonen B, Jaspan JB, Langer BG, Rodman D, Zeidler A.
    Clin Endocrinol (Oxf); 1979 Dec 20; 11(6):639-44. PubMed ID: 394885
    [Abstract] [Full Text] [Related]

  • 14. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T, Ohneda A, Nihei J, Kobayashi T.
    Tohoku J Exp Med; 1982 Dec 20; 138(4):427-40. PubMed ID: 6761899
    [Abstract] [Full Text] [Related]

  • 15. [The response of pancreatic alpha and beta cells to oral glucose stimulation in subjects with risk of diabetes].
    Ferrero E, Casale G, Ravecca D, Ricci C.
    Minerva Med; 1981 Apr 28; 72(17):1065-70. PubMed ID: 6112718
    [Abstract] [Full Text] [Related]

  • 16. Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas).
    Santeusanio F, Massi-Benedetti M, Angeletti G, Calabrese G, Bueti A, Brunetti P.
    J Endocrinol Invest; 1981 Apr 28; 4(1):93-6. PubMed ID: 7016969
    [Abstract] [Full Text] [Related]

  • 17. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I, Vigas M, Jurcovicová J, Repceková D, Kolesár P.
    Diabetes; 1978 Apr 28; 27(4):396-9. PubMed ID: 640244
    [Abstract] [Full Text] [Related]

  • 18. Acromegaly: insensitivity of the pancreatic alpha cell to hyperglycaemia.
    Seino Y, Taminato T, Goto Y, Inoue Y, Kadowaki S, Mori K, Imura H.
    Clin Endocrinol (Oxf); 1978 Dec 28; 9(6):577-81. PubMed ID: 371862
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance.
    Borghi VC, Wajchenberg BL, Cesar FP.
    Metabolism; 1984 Dec 28; 33(12):1068-74. PubMed ID: 6390086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.